Adem Yoldas
Research Interests
Adem Yoldas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Betül Tokgöz Çakır
Department of Perinatology Ankara Etlik City Hospital Ankara Turkey
1 shared publication - Caner Çakır
Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara 06170, Türkiye
1 shared publication - Derya Kızılgöz
Health Sciences University, Faculty of Medicine, Department of Pulmonary Medicine, Atatürk Sanatorium Research Hospital, Ankara, Turkey, Turkey (Türkiye)
1 shared publication - Dilek Çetinkaya Alişar
Department of Physical Medicine and Rehabilitation
1 shared publication - Erhan Okuyan
Department of Obstetrics and Gynecology, Batman Training and Research Hospital, Batman, Türkiye
1 shared publication - Fatma Etgü
Department of Dermatology and Venereology Ordu University Ordu Turkey
1 shared publication
Latest Publications
- 1 July 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (7) , 495-499
Comparison of serum neuropeptide-ff and catestatin levels in hypertensive pregnant women
Aim We aimed to compare the levels of Neuropeptide-FF and Catestatin in the sera of hypertensive and normotensive pregnant women, to determine the possible changes in hypertensive diseases of pregnancy and to examine the possible place of pregnancy in hypertensive diseases. Methods We used the quantitative analysis method to test the hypotheses of the research and examine the relationship between variables. Neuropeptide FF and Catestatin levels were analyzed by Enzyme Linked Immunoassay (ELISA) method. Neuropeptide-FF and Catestatin values of patient and control groups were analyzed with Mann-Whitney and Chi-square tests. Results A higher Catestatin value was determined in the patient group compared to the control group, and this difference was statistically significant(P < .001). Catestatin value in the patient group was 31.61 ± 12.54, and value in the control group was 48.46 ± 22.45 and the relation was statistically found significant (P < .05). The neuropeptide-FF was not statistically significant in the patient and control group compared to the control group (P = .916). Therefore, the Neuropeptide-FF value in the patient group was 134.30 ± 93.72; this value was found as 139.49 ± 96.41 in the control group, but the relation statistically was not found significant (P > .05). According to the analysis results of our study, a statistically significant difference was found for Catestatin at the 5% significance level between the patient group and the control group. Conclusion Decreased NPFF expression in the hypothalamus of hypertensive patients may lead to impaired interaction with other neurochemical systems and therefore may play a role in the pathogenesis of hypertensive disease.
- 1 July 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (7) , 495-499
Comparison of serum neuropeptide-ff and catestatin levels in hypertensive pregnant women
Aim We aimed to compare the levels of Neuropeptide-FF and Catestatin in the sera of hypertensive and normotensive pregnant women, to determine the possible changes in hypertensive diseases of pregnancy and to examine the possible place of pregnancy in hypertensive diseases. Methods We used the quantitative analysis method to test the hypotheses of the research and examine the relationship between variables. Neuropeptide FF and Catestatin levels were analyzed by Enzyme Linked Immunoassay (ELISA) method. Neuropeptide-FF and Catestatin values of patient and control groups were analyzed with Mann-Whitney and Chi-square tests. Results A higher Catestatin value was determined in the patient group compared to the control group, and this difference was statistically significant(P < .001). Catestatin value in the patient group was 31.61 ± 12.54, and value in the control group was 48.46 ± 22.45 and the relation was statistically found significant (P < .05). The neuropeptide-FF was not statistically significant in the patient and control group compared to the control group (P = .916). Therefore, the Neuropeptide-FF value in the patient group was 134.30 ± 93.72; this value was found as 139.49 ± 96.41 in the control group, but the relation statistically was not found significant (P > .05). According to the analysis results of our study, a statistically significant difference was found for Catestatin at the 5% significance level between the patient group and the control group. Conclusion Decreased NPFF expression in the hypothalamus of hypertensive patients may lead to impaired interaction with other neurochemical systems and therefore may play a role in the pathogenesis of hypertensive disease.
- Open Access
- 6 April 2021
- Published by Academician Publishing
- p. 7-12
Gebelikte Bulantı Kusma ve Aile hekiminin Alacağı Tedbirler Nelerdir?
- 6 April 2021
- Published by Academician Publishing
- p. 7-12
Open AccessGebelikte Bulantı Kusma ve Aile hekiminin Alacağı Tedbirler Nelerdir?
- 6 April 2021
- Published by Academician Publishing
Aile Hekimleri için Pratik Kadın Hastalıkları ve Doğum Bilgisi
Değerli aile hekimlerimiz için konu dağılımlarını özenle seçerek klinik pratik yaklaşım ile yazmaya çalıştığımız bu eserin klinik pratikte değerli aile hekimlerimiz için bir yol gösterici olmasını temenni ederim. Bu kitabın yazım süreci boyunca özveri ile çalışan tüm yazarlara teşekkür ederim.Bu kitabı çok sevdiğim eşim Dilan’a ve canım oğlum Emirhan Ali’ye armağan ediyorum.
- 6 April 2021
- Published by Academician Publishing
Aile Hekimleri için Pratik Kadın Hastalıkları ve Doğum Bilgisi
Değerli aile hekimlerimiz için konu dağılımlarını özenle seçerek klinik pratik yaklaşım ile yazmaya çalıştığımız bu eserin klinik pratikte değerli aile hekimlerimiz için bir yol gösterici olmasını temenni ederim. Bu kitabın yazım süreci boyunca özveri ile çalışan tüm yazarlara teşekkür ederim.Bu kitabı çok sevdiğim eşim Dilan’a ve canım oğlum Emirhan Ali’ye armağan ediyorum.